Review Articles 2020-2026

Review literature hub

This note lists all CSV rows labeled exact publication type Review for 2020-2026. Entries are grouped by year and point to PubMed, with local corpus files when those md/txt files exist in the vault.

2026

• Histopathological and Molecular Characteristics of Pediatric Adrenocortical Tumors: where Do we Stand?. Endocr Pathol. 2026. PMID: 41712100. Local full text: 41712100.txt
• Clinical Application of Steroid Profiles and Their Interpretation in Adrenal Disorders. Diagnostics (Basel). 2026. PMID: 41681699. Local full text: 41681699.txt
• [Adrenocortical carcinoma (ACC): current surgical treatment strategies]. Chirurgie (Heidelb). 2026. PMID: 41627430. Local full text: 41627430.md
• Assessment of Adrenal Cortical Neoplasms for the GU Pathologist. Adv Anat Pathol. 2026. PMID: 41606708. Local full text: 41606708.md
• Death receptor 3: A paradoxical biomarker and therapeutic target in pan-cancer. Crit Rev Oncol Hematol. 2026. PMID: 41605339. Local full text: 41605339.md
• Artificial Intelligence and Machine Learning in Pediatric Endocrine Tumors: Opportunities, Pitfalls, and a Roadmap for Trustworthy Clinical Translation. Biomedicines. 2026. PMID: 41595680. Local full text: 41595680.txt
• Adrenal tumors in the elderly. Endocr Relat Cancer. 2026. PMID: 41532570. Local full text: 41532570.md
• Oligometastatic adrenocortical carcinoma: definition and treatment. Curr Opin Oncol. 2026. PMID: 41292251. Local full text: 41292251.txt
• Molecular landscape and biomarker discovery in adrenocortical carcinoma: An integrative review of bioinformatics and translational insights. Pathol Res Pract. 2026. PMID: 41274066. Local full text: 41274066.md
• Potential endogenous lipid ligands for the nuclear receptor transcription factor Steroidogenic Factor-1. Adv Biol Regul. 2026. PMID: 41242911. Local full text: 41242911.txt
• Contemporary Approaches to Adrenocortical Carcinoma. Hematol Oncol Clin North Am. 2026. PMID: 41224440. Local full text: 41224440.md
• Diagnosis and grading of adrenal cortical carcinoma. Virchows Arch. 2026. PMID: 41057662. Local full text: 41057662.txt

2025

• Adrenocortical carcinoma presenting with extensive striae: A case report and literature review. Indian J Cancer. 2025. PMID: 41797592. Local full text: 41797592.md
• Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications. Curr Oncol. 2025. PMID: 41440226. Local full text: 41440226.txt
• Characteristic of Aldosterone-Producing adrenocortical carcinoma: review of the literature. Med Oncol. 2025. PMID: 41385120. Local full text: 41385120.md
• Adrenal-adipose tissue crosstalk in health and disease. Eur J Endocrinol. 2025. PMID: 41370228. Local full text: 41370228.md
• Rare but not forgotten: Therapeutic advancements for rare childhood cancers. Mol Ther Oncol. 2025. PMID: 41322192. Local full text: 41322192.txt
• The Utility of Cabozantinib in the Therapy of Endocrine Tumours. Endocr Pathol. 2025. PMID: 41296120. Local full text: 41296120.md
• The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets. Int J Mol Sci. 2025. PMID: 41226387. Local full text: 41226387.txt
• A comprehensive approach to the CT detection and evaluation of large adrenal masses part 2: malignant adrenal lesions and future directions. Abdom Radiol (NY). 2025. PMID: 41217476. Local full text: 41217476.md
• [Advances in the diagnosis and treatment of adrenal cortex surgical diseases]. Zhonghua Wai Ke Za Zhi. 2025. PMID: 41216730. Local full text: not available in the current corpus md/txt files
• Adrenal hemorrhage: diagnostics, management, and treatment. Review and clinical update. Wideochir Inne Tech Maloinwazyjne. 2025. PMID: 41209753. Local full text: 41209753.txt
• Giant non-functioning adrenocortical carcinoma: a case report and literature review. Chin Clin Oncol. 2025. PMID: 40897300. Local full text: 40897300.md
• Frontiers in Systemic Therapy for Unresectable or Metastatic Adrenocortical Carcinoma: Harnessing Novel Therapeutic Approaches. Clin Med Insights Oncol. 2025. PMID: 40893150. Local full text: 40893150.txt
• Management of cushing’s syndrome in patients with adrenocortical cancer: state of the art and future perspectives. Rev Endocr Metab Disord. 2025. PMID: 40736645. Local full text: 40736645.txt
• Emerging treatment options for adrenocortical carcinoma. Curr Opin Endocrinol Diabetes Obes. 2025. PMID: 40671642. Local full text: 40671642.md
• Adrenocortical organoids: A promising tool for modelling human physiology and translational research. Presse Med. 2025. PMID: 40645443. Local full text: 40645443.md
• The management of adrenocortical carcinoma in the era of precision medicine. Crit Rev Oncol Hematol. 2025. PMID: 40633793. Local full text: 40633793.md
• Therapeutic frontiers in adrenocortical carcinoma: from standards to innovation. Med Oncol. 2025. PMID: 40610651. Local full text: 40610651.md
• Adrenocortical carcinoma during pregnancy. Endokrynol Pol. 2025. PMID: 40586400. Local full text: 40586400.md
• Changing paradigms in evaluating adrenal incidentalomas: Bayesian evaluation of [18F]Fluorodeoxyglucose positron emission tomography use, honed on adrenocortical carcinoma. World J Clin Oncol. 2025. PMID: 40585826. Local full text: 40585826.txt
• The Efficacy and Safety of Multi-Kinase Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Single-Arm Meta-Analysis. Cancers (Basel). 2025. PMID: 40563655. Local full text: 40563655.txt
• Improved and individualized approach to adrenal surgery. Endocr Relat Cancer. 2025. PMID: 40549414. Local full text: 40549414.md
• The argument for screening programs in previvors with Li-Fraumeni syndrome. Expert Rev Anticancer Ther. 2025. PMID: 40542714. Local full text: 40542714.md
• A case of mineralocorticoid intermediate-producing sarcomatoid adrenal cortical carcinoma: case report and review of literature. Endocr J. 2025. PMID: 40533166. Local full text: 40533166.txt
• Endocrine cancer organoids in basic and translational medical research. Sci China Life Sci. 2025. PMID: 40488953. Local full text: 40488953.md
• Adrenal cortical carcinoma - a case series and literature review of aggressive adrenal incidentalomas. Acta Chir Belg. 2025. PMID: 40375728. Local full text: 40375728.md
• Research Landscape on Adrenocortical Carcinoma Over Four Decades. Int J Urol. 2025. PMID: 40375480. Local full text: 40375480.md
• The Landmark Series: Evaluation and Management of Adrenal Incidentalomas. Ann Surg Oncol. 2025. PMID: 40304946. Local full text: 40304946.txt
• Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies. Cancer Treat Rev. 2025. PMID: 40258305. Local full text: 40258305.md
• Update on Adrenocortical Carcinoma. Urol Clin North Am. 2025. PMID: 40250894. Local full text: 40250894.md
• Review of Adrenal Androgen Synthesis, Hypersecretion, and Blockade. Urol Clin North Am. 2025. PMID: 40250889. Local full text: 40250889.md
• Evaluation of the Adrenal Mass in Urologic Practice. Urol Clin North Am. 2025. PMID: 40250886. Local full text: 40250886.md
• Spanish consensus on the diagnosis and management of adrenocortical carcinoma. Endocr Relat Cancer. 2025. PMID: 40215284. Local full text: 40215284.txt
• Oncocytic Adrenal Tumors: A Tri-Focal Review with Integrated Cytopathological, Pathological, and Molecular Perspectives. Acta Cytol. 2025. PMID: 40188823. Local full text: 40188823.txt
• Therapeutic strategies for adrenocortical carcinoma: integrating genomic insights, molecular targeting, and immunotherapy. Front Immunol. 2025. PMID: 40145087. Local full text: 40145087.txt
• Adrenocortical carcinoma: a practical guide for clinicians. Lancet Diabetes Endocrinol. 2025. PMID: 40086465. Local full text: 40086465.md
• Adrenal Mass Evaluation: Suspicious Radiological Signs of Malignancy. Cancers (Basel). 2025. PMID: 40075696. Local full text: 40075696.txt
• A rare manifestation of adrenocortical carcinoma as a mimic of pheochromocytoma: a case report and literature review. Front Endocrinol (Lausanne). 2025. PMID: 40007812. Local full text: 40007812.txt
• LCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications. Int J Mol Sci. 2025. PMID: 40003919. Local full text: 40003919.txt
• Cancer cell xenografts in zebrafish embryos as an experimental tool in drug screening for adrenocortical carcinoma. Minerva Endocrinol (Torino). 2025. PMID: 39998441. Local full text: 39998441.md
• Oncological Management of Adrenocortical Carcinoma: An Update and Critical Review. Oncol Ther. 2025. PMID: 39964565. Local full text: 39964565.txt
• Advancements in the research of the structure, function, and disease-related roles of ARMC5. Front Med. 2025. PMID: 39960568. Local full text: 39960568.md
• Metastatic Alveolar Soft Part Sarcoma Presenting as an Adrenal Incidentaloma: A Case Report with Review of Literature. Int J Surg Pathol. 2025. PMID: 39801176. Local full text: 39801176.md
• Advances in multimodal imaging for adrenal gland disorders: integrating CT, MRI, and nuclear medicine. Jpn J Radiol. 2025. PMID: 39794659. Local full text: 39794659.txt
• Adrenocortical carcinoma with circulating tumor DNA analysis at post-operative recurrence: a case report with review of literature. Endocr J. 2025. PMID: 39617463. Local full text: 39617463.txt
• Updates on WHO 5th edition classification, molecular characteristics and tumor microenvironment of adrenocortical carcinomas. Endocr J. 2025. PMID: 39537177. Local full text: 39537177.txt
• Exploring the FAP-Targeted Therapeutics for Adrenocortical Carcinoma: Choosing the Right Track. Clin Nucl Med. 2025. PMID: 39501489. Local full text: 39501489.md
• Role of radiologists in the diagnosis and management of adrenal disorders. Endocr J. 2025. PMID: 39384399. Local full text: 39384399.txt

2024

• A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma. Cancers (Basel). 2024. PMID: 39682247. Local full text: 39682247.txt
• French AFU Cancer Committee Guidelines - Update 2024-2026 : Assessment of an adrenal incidentaloma and oncological management. Fr J Urol. 2024. PMID: 39581666. Local full text: 39581666.md
• Molecular and Genetics Perspectives on Primary Adrenocortical Hyperfunction Disorders. Int J Mol Sci. 2024. PMID: 39518893. Local full text: 39518893.txt
• The molecular genetics of adrenal cushing. Hormones (Athens). 2024. PMID: 39388056. Local full text: 39388056.md
• Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery. Cancer Manag Res. 2024. PMID: 39263332. Local full text: 39263332.txt
• [Advances in pathological diagnostic scoring systems and specific immune markers of adrenocortical carcinoma]. Zhonghua Bing Li Xue Za Zhi. 2024. PMID: 39231758. Local full text: 39231758.md
• Metastatic Adrenocortical Carcinoma to the Skin: A Case Report and Review of This Unusual Neoplasm. Am J Dermatopathol. 2024. PMID: 39141753. Local full text: 39141753.md
• Systemic Management of Advanced Adrenocortical Carcinoma. Curr Treat Options Oncol. 2024. PMID: 39066856. Local full text: 39066856.md
• A review of mitotane in the management of adrenocortical cancer. Oncologist. 2024. PMID: 39037424. Local full text: 39037424.md
• Adrenal cortical carcinoma: Paediatric aspects - literature review. Pediatr Endocrinol Diabetes Metab. 2024. PMID: 39026485. Local full text: 39026485.txt
• Precocious puberty and other endocrine disorders during mitotane treatment for paediatric adrenocortical carcinoma - case series and literature review. Pediatr Endocrinol Diabetes Metab. 2024. PMID: 39026475. Local full text: 39026475.txt
• The effect of adjuvant mitotane therapy of the adrenocortical carcinoma on the endometrium and its clinical consequences in menstruating women. Literature review and authors’ own experiences. Am J Cancer Res. 2024. PMID: 38726272. Local full text: 38726272.md
• Current prospects of hereditary adrenal tumors: towards better clinical management. Hered Cancer Clin Pract. 2024. PMID: 38532453. Local full text: 38532453.txt
• The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis. Cancers (Basel). 2024. PMID: 38473262. Local full text: 38473262.txt
• Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches. Oncologist. 2024. PMID: 38381694. Local full text: 38381694.txt
• Current Status and Future Direction in the Treatment of Advanced Adrenocortical Carcinoma. Curr Oncol Rep. 2024. PMID: 38381366. Local full text: 38381366.md
• Bioengineered in vitro three-dimensional tumor models in endocrine cancers. Endocr Relat Cancer. 2024. PMID: 38289290. Local full text: 38289290.txt
• Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review. Medicine (Baltimore). 2024. PMID: 38277554. Local full text: 38277554.txt
• What We Know about and What Is New in Primary Aldosteronism. Int J Mol Sci. 2024. PMID: 38255973. Local full text: 38255973.txt
• Immunotherapy for endocrine tumours: a clinician’s perspective. Endocr Relat Cancer. 2024. PMID: 38235757. Local full text: 38235757.md
• Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced pancreatic neuroendocrine tumors: a case series and review of the literature. J Int Med Res. 2024. PMID: 38190848. Local full text: 38190848.txt
• [Interpretation of the 5th edition WHO classification of adrenal cortical tumors]. Zhonghua Bing Li Xue Za Zhi. 2024. PMID: 38178741. Local full text: not available in the current corpus md/txt files
• Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma. Horm Metab Res. 2024. PMID: 38171374. Local full text: 38171374.txt
• Steroid profiling in adrenal disease. Clin Chim Acta. 2024. PMID: 38169194. Local full text: 38169194.md
• Steroidogenic Factor-1 form and function: From phospholipids to physiology. Adv Biol Regul. 2024. PMID: 37802761. Local full text: 37802761.txt

2023

• Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma. Front Endocrinol (Lausanne). 2023. PMID: 38269250. Local full text: 38269250.txt
• Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma. Pharmaceuticals (Basel). 2023. PMID: 38256859. Local full text: 38256859.txt
• Adrenal Cushing’s syndrome in children. Front Endocrinol (Lausanne). 2023. PMID: 38192416. Local full text: 38192416.txt
• Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis. 2023. PMID: 38129399. Local full text: 38129399.txt
• Case Report: Adrenocortical carcinoma in children-symptoms, diagnosis, and treatment. Front Endocrinol (Lausanne). 2023. PMID: 38075063. Local full text: 38075063.txt
• Adrenocortical carcinoma - 12-year observation period in a single centre. Case report with literature review. Pediatr Endocrinol Diabetes Metab. 2023. PMID: 38031835. Local full text: 38031835.txt
• Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia. Biomedicines. 2023. PMID: 38002081. Local full text: 38002081.txt
• Primary adrenal diffuse large B cell Lymphoma with Tumor thrombus in central adrenal vein: a case report and literature review. BMC Endocr Disord. 2023. PMID: 37996831. Local full text: 37996831.txt
• Prognosis of Adrenal Oncocytic Neoplasms (AONs): Literature Review of 287 Cases and Presentation of the Oldest Patient. J Clin Med. 2023. PMID: 37959390. Local full text: 37959390.txt
• Advances in translational research of the rare cancer type adrenocortical carcinoma. Nat Rev Cancer. 2023. PMID: 37857840. Local full text: 37857840.md
• Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease. Cancer Treat Res Commun. 2023. PMID: 37690343. Local full text: 37690343.md
• The rhabdoid variant of adrenocortical carcinoma-Report of three cases and literature review. Indian J Pathol Microbiol. 2023. PMID: 37530357. Local full text: 37530357.md
• Intercostal Artery Laceration after Adrenal Mass Cryoablation. Semin Intervent Radiol. 2023. PMID: 37484442. Local full text: 37484442.md
• The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma - A focus on signaling pathways interplay. Pathol Res Pract. 2023. PMID: 37473498. Local full text: 37473498.md
• Erythrocytosis as the initial presentation of pediatric adrenocortical carcinoma: A case report and review of the literature. Pediatr Blood Cancer. 2023. PMID: 37461126. Local full text: 37461126.md
• miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance. Pathol Res Pract. 2023. PMID: 37418996. Local full text: 37418996.md
• Minimally invasive versus open adrenalectomy for adrenocortical carcinoma: the keys surgical factors influencing the outcomes-a collective overview. Langenbecks Arch Surg. 2023. PMID: 37386332. Local full text: 37386332.md
• Preclinical Models of Adrenocortical Cancer. Cancers (Basel). 2023. PMID: 37296836. Local full text: 37296836.txt
• Pathogenic Insights into DNA Mismatch Repair (MMR) Genes-Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond. Diagnostics (Basel). 2023. PMID: 37296718. Local full text: 37296718.txt
• Lymph node mapping with ICG near-infrared fluorescence imaging: technique and results. Minim Invasive Ther Allied Technol. 2023. PMID: 37261486. Local full text: 37261486.md
• [Adrenohepatic fusion - an unknown but not uncommon phenomenon of clinical importance]. Lakartidningen. 2023. PMID: 37052304. Local full text: 37052304.md
• Adrenocortical tumors in children: Sri Lankan experience from a single center, and a mini review. J Med Case Rep. 2023. PMID: 37046342. Local full text: 37046342.txt
• Rare benign adrenal lesions. Eur J Endocrinol. 2023. PMID: 36943310. Local full text: 36943310.md
• Genetic Testing for Adrenal Tumors-What the Contemporary Surgeon Should Know. Surg Oncol Clin N Am. 2023. PMID: 36925187. Local full text: 36925187.md
• Adrenocortical Carcinoma: Role of Adjuvant and Neoadjuvant Therapy. Surg Oncol Clin N Am. 2023. PMID: 36925185. Local full text: 36925185.md
• Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT). J Cancer. 2023. PMID: 36860927. Local full text: 36860927.txt
• Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline. J Clin Endocrinol Metab. 2023. PMID: 36856782. Local full text: 36856782.md
• Steroidogenic Factor 1, a Goldilocks Transcription Factor from Adrenocortical Organogenesis to Malignancy. Int J Mol Sci. 2023. PMID: 36835002. Local full text: 36835002.txt
• Many Faces of Adrenal Lesions in a Large Patient Cohort: What Has Changed Over the Last Two Decades?. Exp Clin Endocrinol Diabetes. 2023. PMID: 36787883. Local full text: 36787883.md
• A case report and literature review of Carney complex with atrial adenomyxoma. BMC Endocr Disord. 2023. PMID: 36740703. Local full text: 36740703.txt
• Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers. Int J Mol Sci. 2023. PMID: 36674870. Local full text: 36674870.txt
• Treatment of adrenocortical carcinoma: oncological and endocrine outcomes. Curr Opin Urol. 2023. PMID: 36444650. Local full text: 36444650.md
• Pregnancy in patients with adrenocortical carcinoma: a case-based discussion. Rev Endocr Metab Disord. 2023. PMID: 36414840. Local full text: 36414840.md
• Advances in Endocrine Surgery. Surg Oncol Clin N Am. 2023. PMID: 36410918. Local full text: 36410918.md
• Avascular Necrosis of Femur as a Complication of Cushing’s Syndrome Due to Adrenocortical Carcinoma. Am Surg. 2023. PMID: 36134572. Local full text: 36134572.md
• Histopathologic Features of Adrenal Cortical Carcinoma. Adv Anat Pathol. 2023. PMID: 36084635. Local full text: 36084635.md

2022

• Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options. Endocr Oncol. 2022. PMID: 37435451. Local full text: 37435451.txt
• Rectal leiomyosarcoma as the initial phenotypic manifestation of Li-Fraumeni-like syndrome: a case report and review of the literature. J Med Case Rep. 2022. PMID: 36529791. Local full text: 36529791.txt
• Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care. Cancers (Basel). 2022. PMID: 36497381. Local full text: 36497381.txt
• Pediatric adrenocortical carcinoma. Front Endocrinol (Lausanne). 2022. PMID: 36387865. Local full text: 36387865.txt
• Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer. Cancers (Basel). 2022. PMID: 36358665. Local full text: 36358665.txt
• Surgical Management of Adrenocortical Carcinoma: A Literature Review. J Clin Med. 2022. PMID: 36233622. Local full text: 36233622.txt
• Differentiating Polycystic Ovary Syndrome from Adrenal Disorders. Diagnostics (Basel). 2022. PMID: 36140452. Local full text: 36140452.txt
• Disorders of the adrenal cortex: Genetic and molecular aspects. Front Endocrinol (Lausanne). 2022. PMID: 36105398. Local full text: 36105398.txt
• Adrenal functional imaging - which marker for which indication?. Curr Opin Urol. 2022. PMID: 36081395. Local full text: 36081395.md
• Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review. Cureus. 2022. PMID: 36039252. Local full text: 36039252.txt
• The emerging role of 27-hydroxycholesterol in cancer development and progression: An update. Int Immunopharmacol. 2022. PMID: 35978522. Local full text: 35978522.md
• Modulation of Autophagy in Adrenal Tumors. Front Endocrinol (Lausanne). 2022. PMID: 35966083. Local full text: 35966083.txt
• MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma. Cells. 2022. PMID: 35883677. Local full text: 35883677.txt
• Approach to Fine Needle Aspiration of Adrenal Gland Lesions. Adv Anat Pathol. 2022. PMID: 35878423. Local full text: 35878423.md
• Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?. Expert Opin Pharmacother. 2022. PMID: 35876101. Local full text: 35876101.md
• New endpoints in adrenocortical carcinoma studies: a mini review. Endocrine. 2022. PMID: 35869971. Local full text: 35869971.md
• [Are there still indications for open adrenalectomy?]. Chirurgie (Heidelb). 2022. PMID: 35788865. Local full text: 35788865.md
• An update on adrenocortical cell lines of human origin. Endocrine. 2022. PMID: 35764904. Local full text: 35764904.txt
• Adrenal Tumors in Young Adults: Case Reports and Literature Review. Medicina (Kaunas). 2022. PMID: 35744009. Local full text: 35744009.txt
• Association of tumor size and surgical approach with oncological outcomes and overall survival in patients with adrenocortical carcinoma. Urol Oncol. 2022. PMID: 35725937. Local full text: 35725937.txt
• An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms. PET Clin. 2022. PMID: 35717097. Local full text: 35717097.md
• ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma. Eur J Endocrinol. 2022. PMID: 35695575. Local full text: 35695575.md
• CXCR4-targeted theranostics in oncology. Eur J Nucl Med Mol Imaging. 2022. PMID: 35674738. Local full text: 35674738.txt
• Human adrenocortical carcinoma cell line (NCI-H295R): An in vitro screening model for the assessment of endocrine disruptors’ actions on steroidogenesis with an emphasis on cell ultrastructural features. Acta Histochem. 2022. PMID: 35661985. Local full text: 35661985.md
• Use of dissected paraffin block tissue as a source of mRNA for transcriptional profiling and biomarker identification: a review, with preliminary findings in adrenocortical carcinoma tissue. Acta Biochim Pol. 2022. PMID: 35623010. Local full text: 35623010.md
• Association of Surgical Approach With Treatment Burden, Oncological Effectiveness, and Perioperative Morbidity in Adrenocortical Carcinoma. Clin Genitourin Cancer. 2022. PMID: 35618598. Local full text: 35618598.txt
• Radiotherapy for pediatric adrenocortical carcinoma - Review of the literature. Clin Transl Radiat Oncol. 2022. PMID: 35601796. Local full text: 35601796.txt
• FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma. Endocrine. 2022. PMID: 35583844. Local full text: 35583844.txt
• Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen. Endocrine. 2022. PMID: 35567656. Local full text: 35567656.txt
• Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?. Endocrine. 2022. PMID: 35552979. Local full text: 35552979.txt
• Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy. Front Immunol. 2022. PMID: 35464460. Local full text: 35464460.txt
• EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity. Discov Oncol. 2022. PMID: 35435506. Local full text: 35435506.txt
• Approach to androgen excess in women: Clinical and biochemical insights. Clin Endocrinol (Oxf). 2022. PMID: 35349173. Local full text: 35349173.txt
• Adrenocortical carcinoma: Pediatric aspects (Review). Exp Ther Med. 2022. PMID: 35317446. Local full text: 35317446.md
• Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol. 2022. PMID: 35288842. Local full text: 35288842.txt
• Objective assessment of adrenocortical carcinoma driver genes and their correlation with tumor pyruvate kinase M2. Gene. 2022. PMID: 35189247. Local full text: 35189247.md
• Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?. Cancers (Basel). 2022. PMID: 35158739. Local full text: 35158739.txt
• Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour?. Endocrine. 2022. PMID: 35150404. Local full text: 35150404.md
• Spontaneous tumor lysis syndrome in adrenal adenocarcinoma: a case report and review of the literature. J Med Case Rep. 2022. PMID: 35139902. Local full text: 35139902.txt
• Impact of Lymphadenectomy on the Oncologic Outcome of Patients with Adrenocortical Carcinoma-A Systematic Review and Meta-Analysis. Cancers (Basel). 2022. PMID: 35053453. Local full text: 35053453.txt
• Melanoma in patients with Li-Fraumeni syndrome (Review). Exp Ther Med. 2022. PMID: 34934446. Local full text: 34934446.md
• Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma. J Clin Endocrinol Metab. 2022. PMID: 34850906. Local full text: 34850906.md
• The role of molecular profiling in adrenocortical carcinoma. Clin Endocrinol (Oxf). 2022. PMID: 34750847. Local full text: 34750847.md
• Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021. Curr Opin Oncol. 2022. PMID: 34669649. Local full text: 34669649.txt
• Feminizing Adrenocortical Tumors as a Rare Etiology of Isosexual/Contrasexual Pseudopuberty. J Clin Res Pediatr Endocrinol. 2022. PMID: 34380293. Local full text: 34380293.txt

2021

• Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers. Front Endocrinol (Lausanne). 2021. PMID: 35178030. Local full text: 35178030.txt
• Cellular Senescence in Adrenocortical Biology and Its Disorders. Cells. 2021. PMID: 34943980. Local full text: 34943980.txt
• Progress on Genetic Basis of Primary Aldosteronism. Biomedicines. 2021. PMID: 34829937. Local full text: 34829937.txt
• The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review. Biomedicines. 2021. PMID: 34829730. Local full text: 34829730.txt
• Adrenocortical Carcinoma in Childhood: A Systematic Review. Cancers (Basel). 2021. PMID: 34771430. Local full text: 34771430.txt
• Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies. Cancers (Basel). 2021. PMID: 34771418. Local full text: 34771418.txt
• Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?. Cancers (Basel). 2021. PMID: 34680214. Local full text: 34680214.txt
• Metabolic and Endocrine Toxicities of Mitotane: A Systematic Review. Cancers (Basel). 2021. PMID: 34638485. Local full text: 34638485.txt
• Dermatological and endocrine elements in Carney complex (Review). Exp Ther Med. 2021. PMID: 34630667. Local full text: 34630667.md
• The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer. Endocr Relat Cancer. 2021. PMID: 34627131. Local full text: 34627131.md
• Management of Patients With Glucocorticoid-Related Diseases and COVID-19. Front Endocrinol (Lausanne). 2021. PMID: 34594302. Local full text: 34594302.txt
• Beckwith-Wiedemann syndrome: Clinical, histopathological and molecular study of two Tunisian patients and review of literature. Mol Genet Genomic Med. 2021. PMID: 34510813. Local full text: 34510813.txt
• How to Differentiate Benign from Malignant Adrenocortical Tumors?. Cancers (Basel). 2021. PMID: 34503194. Local full text: 34503194.txt
• Management of adrenocortical carcinoma: are we making progress?. Ther Adv Med Oncol. 2021. PMID: 34484430. Local full text: 34484430.txt
• Surgical Management of Adrenocortical Carcinoma: Current Highlights. Biomedicines. 2021. PMID: 34440112. Local full text: 34440112.txt
• Molecular Mechanisms of Functional Adrenocortical Adenoma and Carcinoma: Genetic Characterization and Intracellular Signaling Pathway. Biomedicines. 2021. PMID: 34440096. Local full text: 34440096.txt
• Nucleobindin-2/Nesfatin-1-A New Cancer Related Molecule?. Int J Mol Sci. 2021. PMID: 34361082. Local full text: 34361082.txt
• Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment. Ther Adv Chronic Dis. 2021. PMID: 34349894. Local full text: 34349894.txt
• Giant virilising adrenal cortical carcinoma. Autops Case Rep. 2021. PMID: 34307221. Local full text: 34307221.txt
• [Adrenal imaging: anatomy and pathology (literature review)]. Probl Endokrinol (Mosk). 2021. PMID: 34297499. Local full text: 34297499.txt
• The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging. Eur J Drug Metab Pharmacokinet. 2021. PMID: 34287806. Local full text: 34287806.txt
• A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses. J Nucl Med. 2021. PMID: 34230070. Local full text: 34230070.md
• An ectopic adrenocortical oncocytic adenoma in the liver highly mimicking hepatocellular carcinoma: case report and literature review. Diagn Pathol. 2021. PMID: 34218806. Local full text: 34218806.txt
• Open versus minimally invasive surgery for suspected adrenocortical carcinoma. Transl Androl Urol. 2021. PMID: 34159107. Local full text: 34159107.txt
• The Immunotherapy Landscape in Adrenocortical Cancer. Cancers (Basel). 2021. PMID: 34071333. Local full text: 34071333.txt
• The Sexually Dimorphic Adrenal Cortex: Implications for Adrenal Disease. Int J Mol Sci. 2021. PMID: 34063067. Local full text: 34063067.txt
• Case Report: Complete Necrosis of a Large Adrenocortical Cancer and Liver Metastases Achieved by Selective Arterial Embolization: A Case Study and Review of Literature. Front Endocrinol (Lausanne). 2021. PMID: 33995288. Local full text: 33995288.txt
• Advanced Adrenocortical Carcinoma: Current Perspectives on Medical Treatment. Horm Metab Res. 2021. PMID: 33962475. Local full text: 33962475.md
• Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?. Cancers (Basel). 2021. PMID: 33918733. Local full text: 33918733.txt
• Emerging drugs for the treatment of adrenocortical carcinoma. Expert Opin Emerg Drugs. 2021. PMID: 33896321. Local full text: 33896321.md
• How close are we to personalized mitotane dosing in the treatment of adrenocortical carcinoma? State of the art and future perspectives. Expert Opin Drug Metab Toxicol. 2021. PMID: 33886381. Local full text: 33886381.md
• Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors. Pediatr Blood Cancer. 2021. PMID: 33818883. Local full text: 33818883.md
• Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance. Biomedicines. 2021. PMID: 33809752. Local full text: 33809752.txt
• Angiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors. Cancers (Basel). 2021. PMID: 33804534. Local full text: 33804534.txt
• Thermal ablation in adrenal disorders: a discussion of the technology, the clinical evidence and the future. Curr Opin Endocrinol Diabetes Obes. 2021. PMID: 33741778. Local full text: 33741778.txt
• Steroid Sulfation in Adrenal Tumors. J Clin Endocrinol Metab. 2021. PMID: 33739426. Local full text: 33739426.md
• Current Status and Future Targeted Therapy in Adrenocortical Cancer. Front Endocrinol (Lausanne). 2021. PMID: 33732213. Local full text: 33732213.txt
• Approach to patients with European Network for the Study of Adrenal Tumor stages I and II adrenocortical carcinomas. Curr Opin Endocrinol Diabetes Obes. 2021. PMID: 33709971. Local full text: 33709971.md
• [Hyperaldosteronism]. Internist (Berl). 2021. PMID: 33599784. Local full text: 33599784.md
• Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging. Biomedicines. 2021. PMID: 33578929. Local full text: 33578929.txt
• The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives. Biomedicines. 2021. PMID: 33578890. Local full text: 33578890.txt
• The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma. Biomedicines. 2021. PMID: 33498467. Local full text: 33498467.txt
• Pharmacological profile and effects of mitotane in adrenocortical carcinoma. Br J Clin Pharmacol. 2021. PMID: 33382119. Local full text: 33382119.md
• Medical management of adrenocortical carcinoma: Current recommendations, new therapeutic options and future perspectives. Ann Endocrinol (Paris). 2021. PMID: 33279475. Local full text: 33279475.md
• Analysis of steroid profiles by mass spectrometry: A new tool for exploring adrenal tumors?. Ann Endocrinol (Paris). 2021. PMID: 33278379. Local full text: 33278379.md
• Adrenocortical carcinoma: current treatment options. Curr Opin Oncol. 2021. PMID: 33186181. Local full text: 33186181.md
• Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome. J Clin Endocrinol Metab. 2021. PMID: 33185660. Local full text: 33185660.md
• ENSAT registry-based randomized clinical trials for adrenocortical carcinoma. Eur J Endocrinol. 2021. PMID: 33166271. Local full text: 33166271.md
• Management of adrenocortical carcinoma in Western Australia: a perspective over 14 years. ANZ J Surg. 2021. PMID: 32627365. Local full text: 32627365.md
• Two Subsequent Metachroneus Solid Tumors: Oncocytic Variant Adrenocortical Carcinoma and Rhabdomyosarcoma of Childhood: Case Report and Literature Review. J Clin Res Pediatr Endocrinol. 2021. PMID: 32539319. Local full text: 32539319.txt

2020

• Adrenocortical carcinoma: a literature review. Transl Cancer Res. 2020. PMID: 35117470. Local full text: 35117470.txt
• American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach. Endocr Pract. 2020. PMID: 33875173. Local full text: 33875173.txt
• [French ccAFU guidelines - update 2020-2022: malignancy assessment of an adrenal incidentaloma]. Prog Urol. 2020. PMID: 33349429. Local full text: 33349429.md
• Germline TP53 Testing in Breast Cancers: Why, When and How?. Cancers (Basel). 2020. PMID: 33327514. Local full text: 33327514.txt
• Medical Approaches in Adrenocortical Carcinoma. Biomedicines. 2020. PMID: 33260476. Local full text: 33260476.txt
• New Prognostic Indicators in Pediatric Adrenal Tumors: Neuroblastoma and Adrenal Cortical Tumors, Can We Predict When These Will Behave Badly?. Surg Pathol Clin. 2020. PMID: 33183724. Local full text: 33183724.md
• Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion. Radiographics. 2020. PMID: 33064623. Local full text: 33064623.md
• The Potential of Steroid Profiling by Mass Spectrometry in the Management of Adrenocortical Carcinoma. Biomedicines. 2020. PMID: 32872281. Local full text: 32872281.txt
• Key MicroRNA’s and Their Targetome in Adrenocortical Cancer. Cancers (Basel). 2020. PMID: 32781574. Local full text: 32781574.txt
• Pediatric adrenocortical tumours. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32636100. Local full text: 32636100.md
• Next-generation therapies for adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32622829. Local full text: 32622829.md
• “How We Do It” - A Practical Approach to Percutaneous Adrenal Ablation Techniques. Tech Vasc Interv Radiol. 2020. PMID: 32591192. Local full text: 32591192.md
• Adrenocortical tumors in children. Semin Pediatr Surg. 2020. PMID: 32571512. Local full text: 32571512.md
• Adrenocortical tumorigenesis: Lessons from genetics. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32507359. Local full text: 32507359.txt
• The role of immune checkpoint inhibitor therapy in advanced adrenocortical carcinoma revisited: review of literature. J Endocrinol Invest. 2020. PMID: 32468513. Local full text: 32468513.md
• Past, Present and Future of Epigenetics in Adrenocortical Carcinoma. Cancers (Basel). 2020. PMID: 32414074. Local full text: 32414074.txt
• Tumors presenting in both pediatric and adult patients: a case-based review of pathology and imaging features for the radiologist. Abdom Radiol (NY). 2020. PMID: 32322909. Local full text: 32322909.md
• Update on in-vivo preclinical research models in adrenocortical carcinoma. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 32304391. Local full text: 32304391.txt
• Pediatric adrenocortical tumor - review and management update. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 32304390. Local full text: 32304390.md
• Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies. Horm Cancer. 2020. PMID: 32303972. Local full text: 32303972.md
• Adrenal Incidentaloma. Endocr Rev. 2020. PMID: 32266384. Local full text: 32266384.txt
• Surgery for adrenocortical carcinoma: When and how?. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32265101. Local full text: 32265101.md
• Evaluation and management of adrenal neoplasms: endocrinologist and endocrine surgeon perspectives. Abdom Radiol (NY). 2020. PMID: 32189021. Local full text: 32189021.md
• New perspectives for mitotane treatment of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32179008. Local full text: 32179008.md
• Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions. Cancers (Basel). 2020. PMID: 32098326. Local full text: 32098326.txt
• Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management. Abdom Radiol (NY). 2020. PMID: 31894378. Local full text: 31894378.md
• Effects of Adipocyte-derived Factors on the Adrenal Cortex. Curr Mol Pharmacol. 2020. PMID: 31613736. Local full text: 31613736.md
• Adrenal disorders in pregnancy, labour and postpartum - an overview. J Obstet Gynaecol. 2020. PMID: 31469031. Local full text: 31469031.md
• Rare Genitourinary Malignancies: Current Status and Future Directions of Immunotherapy. Eur Urol Focus. 2020. PMID: 30910391. Local full text: 30910391.md

Notes

• Review entries in this band: 244
• Entries with local corpus md/txt files: 242
• Entries missing local corpus md/txt files: 2